Annika de Jong (A de Jong)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Venues

Journal of thrombosis and haemostasis : JTH

Thrombosis and haemostasis

Research and practice in thrombosis and haemostasis

Blood advances

NYU Langone Health

Universiteit Leiden (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NYU Langone Health Jul 29 2020

United States

Postdoctoral researcher :: Medicine

Leiden University Medical Center Apr 01 2014 - Jul 13 2020

Netherlands

PhD candidate :: Einthoven laboratory for vascular and regenerative medicine

Education History

Universiteit Leiden Sep 01 2011 - Feb 28 2014

Netherlands

MSC :: Leiden Institute of Chemistry

Technische Universiteit Delft Sep 01 2007 - Aug 31 2011

Netherlands

BSC :: Faculty of Applied sciences

Universiteit Leiden Sep 01 2007 - Aug 31 2011

Netherlands

BSC :: Leiden Institute of Chemistry

Publications

Yvonne K Jongejan, Elisa Schrader Echeverri, Richard J Dirven, Kalina Paunovska, Noa A Linthorst, Annika de Jong, Johannes C Wellershoff, Kim Daniëlle van der Gouw, Bart J M van Vlijmen, James E Dahlman, Jeroen C J Eikenboom
Small interfering RNA-mediated allele-selective silencing of von Willebrand factor in vitro and in vivo. Blood advances (2023)
Marie-Daniéla Dubois, Ivan Peyron, Olivier-Nicolas Pierre-Louis, Serge Pierre-Louis, Johalène Rabout, Pierre Boisseau, Annika de Jong, Sophie Susen, Jenny Goudemand, Rémi Neviere, Pascal Fuseau, Olivier D Christophe, Peter J Lenting, Cecile V Denis, Caterina Casari
Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization. Research and practice in thrombosis and haemostasis 6 (4) (2022)
Suzan de Boer, Mackenzie Bowman, Colleen Notley, Aomei Mo, Patricia Lima, Annika de Jong, Richard Dirven, Ester Weijers, David Lillicrap, Paula James, Jeroen C J Eikenboom
Endothelial characteristics in healthy endothelial colony forming cells; generating a robust and valid ex vivo model for vascular disease. Journal of thrombosis and haemostasis : JTH 18 (10) (2020)
Annika de Jong, Richard J Dirven, Johan Boender, Ferdows Atiq, Seyed Yahya Anvar, Frank W G Leebeek, Bart J M van Vlijmen, Jeroen C J Eikenboom
Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA. Thrombosis and haemostasis 120 (11) (2020)
Annika de Jong, Ester Weijers, Richard J Dirven, Suzan de Boer, Jasmin Streur, Jeroen C J Eikenboom
Variability of von Willebrand factor-related parameters in endothelial colony forming cells. Journal of thrombosis and haemostasis : JTH 17 (9) (2019)
Annika de Jong, R J Dirven, J A Oud, D Tio, B J M van Vlijmen, Jeroen C J Eikenboom
Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor. Journal of thrombosis and haemostasis : JTH 16 (7) (2018)

Annika de Jong.css-eqlu8i{font-size:small;padding-left:4px;} (A de Jong)

Publication Activity (10 Years)

Top Topics

Top Venues

Annika de Jong (A de Jong)